Supply, Installation, Testing, Commissioning And 2 Years Annual Maintenance Contract Of Energy Management System Along With Mfm Meters And Other Hardware
Supply of Srph154036-Mri Conditional Dual Chamber Pacemaker Rate Responsive Ddd R With Appropriate Atrial And Ventricular Bipolar Steroid Eluting Lead Mri Conditi Onal With Life Warranty Provision Of Pacing Therapy For The Use Of The Patients Lif E-Time Including Any No. Of Pulse Generator Replacements As Clinically Required. S Hould Have The Latest Technological Features To Provide Proportionate, Smooth A Nd Appropriate Response Of Pacing Rate To Increased Metabolic Demand, Should Pr Ovide For Atrial And Ventricular Pacing And Sensing With Choice Of At Least 16 Mode S Of Operation, Appropriate Safety Features To Avoid Cross Talk, Optimum Flexibilit Y Of Programming Including Minimal Av Delay Of 30Msec Or Less And Atrial Sensitivit Y Of 0.2Mv Or Less, Detailed Data Storage With Easy Retrieval And Display Of Advanc Ed Diagnostics For Ease Of Clinical Follow Up & Maximal Longevity. Should Be Capabl E Of Programming For Prolonging Longevity And Maximal Cost Effectiveness. Shoul D Be Capable Of Providing Reliable Ventricular Capture With Lowest Battery Drain S O As To Provide Maximum Longevity Of The Pacing System. Preferably As An Automati C Feature Where The Pulse Generator Can Perform A Periodic Threshold Test And R Eliably Verify Ventricular Capture And Adjust Ventricular Pulse Output Parameter S To Minimize Battery Drain Without Compromising Patient Safety. Should Have Feat Ures For Automatic Management Of Arrhythmias Including Pacemaker Mediated Arr Hythmias As Well As Automatic Mode Switching Mode Switch Should Be To And From Ddd To Ddi/Vvir, Provision Of Rate Responsive Pacing After Mode Switch And Automat Ic Reversion To Ddd After Termination Of Mode Switch Triggering Arrhythmias. Sho Uld Have Algorithms To Promote Intrinsic Conduction. Both Atrial And Ventricular Channels Should Have Provision For High Energy Output I.E. Up To At Least 6.0 Volts Pulse Amplitude And Pulse Width Up To Atleast 1.0 Ms, Follow Up Diagnosis And Repro Gramming Should Be Rendered As Effective As Possible Through Provision Of Adequ Ate Information Management Systems On The Programmer. Mri Compatible Leads Sho Uld Be Bipolar, Steroid Eluting And Low Profile Either Tined Or Active Fixation Type 7F Or Smaller Introducer Individually. Leads Should Be From The Same Manufacture R I.E. Manufactured By The Same Company As The Pulse Generator, Not Outsourced A Nd Marketed By Another Company. Pulse Generator And Leads Should Be Suitable Fo R Adult And Paediatric Patients. The Manufacturer / Supplier Should Submit Proof O F Supply To A Major Government Institute. Publications Supporting The Safety And E Fficacy Of The Pacemaker Device And The Leads In Clinical Use Should Be Available In Peer Reviewed Journals. The Latest Programmer With Up Dated Software Should Be Available At All Times Permanently In The Hospital. The Programmer Should Have Fac Ilities For Simultaneous Display Of Multiple Surface Ecg Leads, Intracardiac Electr Ograms, Event Markers, Electronic Calipers And For Recording The Same Both On P Aper And In Electronic Storage Media E.G. Compact Disc Etc., Unit:No
Re-Certification Of Iso 50001:2018 Energy Management System Enms In Elaau/Clw/Dankuni Along With 1St And 2Nd Surveillance Audit And Requisite Training To The Staff Of This Unit.
Integrated Management System Ims, Energy Management System Enms & 5S Recertification For Elw/Bsl.
Supply of Mri Conditional Dual Chamber Implantable Cardioverter Defibrillator System With Df - 4 Connector And Option Of Dual Shocking Coil.. Sr Ph 154066-Mri Conditional Dual Chamber Implantable Cardioverter Defibri Llator System With Appropriate Atrial And Ventricular Pace / Sense Leads With Df - 4 C Onnector And Option Of Dual Shocking Coil Leads And Accessories. System Should Hav E Advanced Features For The Reliable Detection And Management Of Ventricular Tach Ycardia And Ventricular Fibrillation, Including Features To Differentiate Supra-Ventr Icular Tachycardia From Ventricular Tachycardia And Features To Avoid Inappropriat E Shocks, Tiered Therapy Delivery, Choice Of Atp Protocols And Shock Energies, And S Hould Be Capable Of Delivering Maximum Energy Of 35J Or More And Should Have Featu Res For Management Of High Defibrillation Energy Requirement. Charge Times Should Be Within Clinically Acceptable Limits Throughout The Lifetime Of The Device.Leads Sho Uld Be Low Profile And Choice Of Both Active Or Passive Fixation Leads Should Be Avail Able. Should Have Features For Automatically Alerting The Patient In The Event Of A Ba Ttery Or Lead Fault. Data Storage, Retrieval And Display Should Be Efficient And User Friendly. Data Storage Should Include Episode Details, Therapy Delivered And Results And Electrogram Storage And Should Be Comprehensive. Bradycardia Pacing Includi Ng Independently Programmable Parameters For High Output For Post-Shock Pacing Should Be Available. Warranty Terms Should Be Specified Clearly Along With The Quot Ation. Firms Should Submit Detailed Literature Of The Item In A Bulletin/Tutorial Forma T Which Should Contain All The Details About The Product. Compliance Statement Of E Ach Specification To Be Submitted. The Firm Quoting The Tender Should Submit A Letter Of Authorisation From The Principal Firm/Original Equipment Manufacturer. The Manuf Acturer / Supplier Should Submit Proof Of Supply To A Major Government Institute. Th E Safety And Efficacy Of The Icd Device And The Lead In Clinical Use Should Be Documen Ted In Scientific Publications. All The Above Mentioned Specifications Are Essential An D Mandatory And Should Be Submitted At The Time Of Initial Tender Submission. Unit:No
Supply of Mri Conditional Dual Chamber Implantable Cardioverter Defibrillator System. Srph154064-Mri Conditional Dual Chamber Implantable Cardioverter Defibril Lator System With Appropriate Atrial And Ventricular Pace / Sense Leads And Option O F Dual Shocking Coil Leads And Accessories. System Should Have Advanced Features F Or The Reliable Detection And Management Of Ventricular Tachycardia And Ventricul Ar Fibrillation, Including Features To Differentiate Supra-Ventricular Tachycardia Fr Om Ventricular Tachycardia And Features To Avoid Inappropriate Shocks, Tiered Ther Apy Delivery, Choice Of Atp Protocols And Shock Energies, And Should Be Capable Of D Elivering Maximum Energy Of 35J Or More And Should Have Features For Management O F High Defibrillation Energy Requirement. Charge Times Should Be Within Clinically Ac Ceptable Limits Throughout The Lifetime Of The Device. Leads Should Be Low Profile An D Choice Of Both Active Or Passive Fixation Leads Should Be Available. Should Have Fea Tures For Automatically Alerting The Patient In The Event Of A Battery Or Lead Fault. Data Storage, Retrieval And Display Should Be Efficient And User Friendly. Data Stora Ge Should Include Episode Details, Therapy Delivered And Results And Electrogram St Orage And Should Be Comprehensive. Bradycardia Pacing Including Independently Pr Ogrammable Parameters For High Output For Post-Shock Pacing Should Be Available. Warranty Terms Should Be Specified Clearly Along With The Quotation. Firms Should S Ubmit Detailed Literature Of The Item In A Bulletin/Tutorial Format Which Should Conta In All The Details About The Product. Compliance Statement Of Each Specification To B E Submitted. The Firm Quoting The Tender Should Submit A Letter Of Authorisation Fro M The Principal Firm/Original Equipment Manufacturer. The Manufacturer / Supplier Sh Ould Submit Proof Of Supply To A Major Government Institute. The Safety And Efficac Y Of The Icd Device And The Lead In Clinical Use Should Be Documented In Scientific Publ Ications. All The Above Mentioned Specifications Are Essential And Mandatory And Sho Uld Be Submitted At The Time Of Initial Tender Submission. Unit: No
